Skip to Content

Steris PLC STE Stock Quote

| Rating as of

Morningstar‘s Stock Analysis STE

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Steris' Sales Fall Short of Expectations in Q1; Maintaining FVE on Unchanged Long-Term Forecasts

Aaron Degagne Equity Analyst

Analyst Note

| Aaron Degagne |

While narrow-moat Steris' results did not quite meet our expectations in the fiscal first quarter and also fell short of FactSet-aggregated consensus, this was not enough to move the needle on our $201 fair value estimate. The shares now look fairly valued.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics STE

Company Profile STE

Business Description

Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.

5960 Heisley Road
Mentor, OH, 44060
T +1 440 354-2600
Industry Medical Devices
Most Recent Earnings Jun 30, 2022
Fiscal Year End Mar 31, 2023
Stock Type
Employees 16,422